To nurture a drug through the tortuous process of drug approval is an extraordinarily expensive business. For a pharmaceutical company to gain a return on an investment of many millions, it needs to ensure that the drug will have a broad use among a...
YOU CAN'T MAKE IT UP: Well, you can if you're a drug company
ANTIDEPRESSANTS: They're great for two-year-olds
BRIBERY: Glaxo faces serious charges in Italy
The injectable contraceptive Depo-Provera may cause a loss of bone density. America’s drugs regulator, the Food and Drug Administration (FDA), has added a new ‘black-box’ warning to the drug, highlighting the problems with its prolonged use.
What Doctors Don't Tell You